TW202411429A - Promoter library and application thereof in different bacteria - Google Patents
Promoter library and application thereof in different bacteria Download PDFInfo
- Publication number
- TW202411429A TW202411429A TW112144768A TW112144768A TW202411429A TW 202411429 A TW202411429 A TW 202411429A TW 112144768 A TW112144768 A TW 112144768A TW 112144768 A TW112144768 A TW 112144768A TW 202411429 A TW202411429 A TW 202411429A
- Authority
- TW
- Taiwan
- Prior art keywords
- promoter
- library
- seq
- promoter library
- expression
- Prior art date
Links
- 241000894006 Bacteria Species 0.000 title claims abstract description 32
- 230000014509 gene expression Effects 0.000 claims abstract description 41
- 238000010276 construction Methods 0.000 claims abstract description 7
- 238000010353 genetic engineering Methods 0.000 claims abstract description 4
- 239000002773 nucleotide Substances 0.000 claims abstract description 3
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 3
- 108090000623 proteins and genes Proteins 0.000 claims description 17
- 244000005700 microbiome Species 0.000 claims description 14
- 238000000034 method Methods 0.000 claims description 8
- 230000000813 microbial effect Effects 0.000 claims description 8
- 239000013598 vector Substances 0.000 claims description 8
- 238000013518 transcription Methods 0.000 claims description 6
- 230000035897 transcription Effects 0.000 claims description 6
- 230000001105 regulatory effect Effects 0.000 claims description 5
- 241000588722 Escherichia Species 0.000 claims description 4
- 241000589516 Pseudomonas Species 0.000 claims description 4
- 241000187747 Streptomyces Species 0.000 claims description 4
- 241000193830 Bacillus <bacterium> Species 0.000 claims description 3
- 241000186146 Brevibacterium Species 0.000 claims description 3
- 241000186216 Corynebacterium Species 0.000 claims description 3
- 241001467578 Microbacterium Species 0.000 claims description 3
- 108700005443 Microbial Genes Proteins 0.000 claims description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 claims description 2
- 238000000855 fermentation Methods 0.000 claims description 2
- 230000004151 fermentation Effects 0.000 claims description 2
- 238000010362 genome editing Methods 0.000 claims description 2
- 241000186063 Arthrobacter Species 0.000 claims 1
- 230000033228 biological regulation Effects 0.000 abstract description 5
- 241000588724 Escherichia coli Species 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 12
- 239000013612 plasmid Substances 0.000 description 10
- 238000012360 testing method Methods 0.000 description 6
- 241001528539 Cupriavidus necator Species 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 230000004913 activation Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 241000186226 Corynebacterium glutamicum Species 0.000 description 3
- 241000478360 Eleutherodactylus rhodesi Species 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000000684 flow cytometry Methods 0.000 description 3
- 239000012634 fragment Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 238000011144 upstream manufacturing Methods 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 2
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- -1 fatty acid esters Chemical class 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 238000009776 industrial production Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 108020004707 nucleic acids Proteins 0.000 description 2
- 150000007523 nucleic acids Chemical class 0.000 description 2
- 102000039446 nucleic acids Human genes 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 239000013600 plasmid vector Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 108020004513 Bacterial RNA Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 244000247747 Coptis groenlandica Species 0.000 description 1
- 235000002991 Coptis groenlandica Nutrition 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- 238000007702 DNA assembly Methods 0.000 description 1
- 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 241000186394 Eubacterium Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 238000012408 PCR amplification Methods 0.000 description 1
- 108700008625 Reporter Genes Proteins 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000006696 biosynthetic metabolic pathway Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000021615 conjugation Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 108091005946 superfolder green fluorescent proteins Proteins 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 239000013603 viral vector Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2830/00—Vector systems having a special element relevant for transcription
- C12N2830/34—Vector systems having a special element relevant for transcription being a transcription initiation element
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/185—Escherichia
- C12R2001/19—Escherichia coli
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Landscapes
- Genetics & Genomics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Wood Science & Technology (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
本發明涉及基因工程技術領域,尤其涉及一種啓動子庫及其在不同細菌中的應用。The present invention relates to the field of genetic engineering technology, and in particular to a promoter library and its application in different bacteria.
合成生物學以系統化設計和工程學理念為基礎,旨在通過工程科學的原理,降低天然生物系統的研究複雜性或者重構複雜的人工生物系統。在具體的實踐中,可以通過生物元件的精細調控實現對生物合成途徑的控制以實現目標產品的最佳生產;也可以通過不同生物元件以串聯、反饋或者前饋等形式連接組成具有預期功能的生物系統。其中,生物元件是合成生物系統中最核心和最重要的基礎。Synthetic biology is based on systematic design and engineering concepts, and aims to reduce the complexity of natural biological system research or reconstruct complex artificial biological systems through the principles of engineering science. In specific practice, the biosynthetic pathway can be controlled through the precise regulation of biological components to achieve the optimal production of target products; different biological components can also be connected in series, feedback or forward to form a biological system with expected functions. Among them, biological components are the core and most important foundation of synthetic biological systems.
啓動子是能夠决定轉錄起始位置並控制基因表達强度的一類生物元件,是基因表達系統的核心部分之一。通過啓動子的强弱來實現對不同基因活動的控制是一種常用的生物調控手段。因此,需要包含一系列不同强度啓動子的啓動子庫以滿足對不同基因表達强度的需求。Promoters are a type of biological element that can determine the start position of transcription and control the strength of gene expression. They are one of the core parts of the gene expression system. Controlling different gene activities by the strength of the promoter is a common biological regulation method. Therefore, a promoter library containing a series of promoters of different strengths is needed to meet the needs of different gene expression strengths.
工業微生物是指來源自然界、可以直接(或加以改良後)應用於實際生產的一類微生物。目前已經成功應用於工業生產的細菌包括大腸桿菌、谷氨酸棒狀桿菌、鏈黴菌等,還有一些細菌被視為潜在的工業菌株,如假單胞菌、羅氏真養菌、自產乙醇梭菌桿菌等。通過啓動子對基因進行精細調控可以實現工業微生物的合成途徑優化進而提升產量和轉化率,降低生產成本。Industrial microorganisms refer to a type of microorganisms that originate from nature and can be directly (or after being modified) used in actual production. Bacteria that have been successfully used in industrial production include Escherichia coli, Corynebacterium glutamicum, Streptomyces, etc. Some bacteria are considered potential industrial strains, such as Pseudomonas, Eutrophilia rosea, and Clostridium difficile. Precise regulation of genes through promoters can optimize the synthesis pathway of industrial microorganisms, thereby increasing yield and conversion rate and reducing production costs.
大腸桿菌作為微生物研究的模式生物,具有清晰的遺傳背景,與其相關的啓動子等基因元件的開發也相對成熟。但是在某一細菌中構建的生物元件(例如啓動子庫)不一定適用於其他細菌,這在一定程度上制約了生物元件的拓展和應用。As a model organism for microbial research, Escherichia coli has a clear genetic background, and the development of related gene elements such as promoters is relatively mature. However, biological elements constructed in a certain bacterium (such as promoter libraries) may not be applicable to other bacteria, which to some extent restricts the expansion and application of biological elements.
羅氏真養菌(Ralstonia eutropha,已更名為殺蟲貪銅菌(Cupriavidus necator)),屬於革蘭氏陰性菌,可以利用糖類、油脂等多種碳源作為底物,是PHA生產的模式菌株,具有很高的工業化生產應用潜力。目前,對於羅氏真養菌的基礎研究處於初始階段,雖然已經有文獻報道了一些可以在羅氏真養菌中使用的生物元件,但是大部分是將大腸桿菌中的生物元件遷移到新的底盤中進行嘗試,在這個過程中經常出現元件測試結果與原底盤不匹配的結果。生物元件的匱乏直接制約了羅氏真養菌作為工業微生物的開發和應用。因此,開發可以在不同細菌中穩定轉移使用的生物元件至關重要。Ralstonia eutropha (now renamed Cupriavidus necator) is a Gram-negative bacterium that can use a variety of carbon sources such as sugars and lipids as substrates. It is a model strain for PHA production and has high potential for industrial production and application. At present, basic research on Ralstonia eutropha is in its initial stage. Although some literature has reported some biological components that can be used in Ralstonia eutropha, most of them are attempts to migrate biological components in Escherichia coli to new chassis. In this process, the component test results often do not match the original chassis. The scarcity of biological components directly restricts the development and application of Ralstonia eutropha as an industrial microorganism. Therefore, it is crucial to develop biological components that can be stably transferred and used in different bacteria.
本發明提供一種啓動子庫及其在不同細菌中的應用。The present invention provides a promoter library and its application in different bacteria.
本發明以一段原始啓動子序列為基礎,通過將該啓動子序列中的鹼基進行飽和突變(改變n個鹼基可得到4 n種突變)改變啓動子强度,得到具有較廣啓動子强度範圍、且在不同細菌之間具有較高强度一致性的啓動子庫。 The present invention is based on an original promoter sequence, and changes the promoter strength by saturating the bases in the promoter sequence (changing n bases can obtain 4 n mutations), thereby obtaining a promoter library with a wider promoter strength range and higher strength consistency among different bacteria.
具體地,本發明提供以下技術方案:Specifically, the present invention provides the following technical solutions:
本發明提供一種啓動子庫,所述啓動子庫包括核苷酸序列如SEQID NO.1所示的啓動子,其中,n代表a、t、c、g中的任意一種。The present invention provides a promoter library, which includes a promoter having a nucleotide sequence as shown in SEQ ID NO.1, wherein n represents any one of a, t, c, and g.
上述啓動子庫中的啓動子序列具體如下(SEQ ID NO.1,5’-3’): ttcgtcaggccacatagctttcttgttctgatcggaacgatcgttggctgtg aaaaaatttat ttgcttagcccgacgcccgcggg nnnaata gaattcactagtttaactttaagaa(其中,n代表a、t、c、g中的任意一種)。 The promoter sequence in the above promoter library is as follows (SEQ ID NO.1, 5'-3'): ttcgtcaggccacatagctttcttgttctgatcggaacgatcgttggctgtgaaaaaatttat ttgctt agcccgacgcccgcggg nnnaat a gaattcactagtttaactttaagaa (wherein n represents any one of a, t, c, and g).
上述啓動子序列具體包含以下幾個部分:上游序列(Up-element,下劃線序列的上游序列),核心區(下劃線標註的序列,其中-10區和-35區分別加粗標註),下游序列(Spacer,下劃線序列的下游序列)。其中,核心區部分是啓動子發揮“開/關”功能的部分,上游序列(UP-element)可以通過與細菌RNA聚合酶相互作用影響啓動子的强度,下游序列為啓動子和其他序列的間隔序列。The above promoter sequence specifically includes the following parts: upstream sequence (Up-element, upstream sequence of underlined sequence), core region (sequence marked with underline, where -10 region and -35 region are marked with bold respectively), downstream sequence (Spacer, downstream sequence of underlined sequence). Among them, the core region is the part where the promoter plays the "on/off" function, the upstream sequence (UP-element) can affect the strength of the promoter by interacting with bacterial RNA polymerase, and the downstream sequence is the spacer sequence between the promoter and other sequences.
上述啓動子序列中,n可以為a、t、c、g中的任意一種,因此上述啓動子序列共包含64種不同的啓動子序列。In the above activation subsequence, n can be any one of a, t, c, and g, so the above activation subsequence includes 64 different activation subsequences in total.
在本發明的一些實施方式中,所述啓動子庫包括1-64個啓動子。In some embodiments of the present invention, the promoter library includes 1-64 promoters.
在本發明的一些實施方式中,所述啓動子庫包括2-64個啓動子。In some embodiments of the present invention, the promoter library includes 2-64 promoters.
在本發明的一些實施方式中,所述啓動子庫包括64個啓動子。In some embodiments of the present invention, the promoter library includes 64 promoters.
在本發明的一些實施方式中,所述啓動子庫包括核苷酸序列如SEQ ID NO.2-41所示的啓動子。In some embodiments of the present invention, the promoter library includes promoters with nucleotide sequences as shown in SEQ ID NO.2-41.
經驗證,以上所述的啓動子庫中的啓動子的强度動態範圍達10 3倍(以綠色螢光蛋白為報告基因),可以在不同細菌(例如,大腸桿菌和羅氏真養菌)中發揮功能;且相同啓動子在不同細菌中的强度具有較高的一致性,即啓動子庫具有不同細菌之間的可移植性。 It has been verified that the dynamic range of the strength of the promoters in the above-mentioned promoter library is up to 10 3 times (with green fluorescent protein as the reporter gene), and can function in different bacteria (for example, Escherichia coli and E. rhodesiae); and the strength of the same promoter in different bacteria has a high consistency, that is, the promoter library has portability between different bacteria.
本發明提供一種啓動子,所述啓動子為以上所述的啓動子庫中的啓動子。The present invention provides a promoter, which is a promoter in the promoter library mentioned above.
在本發明的一些實施方式中,上述提供的啓動子為所述啓動子庫中的任意一個啓動子。In some embodiments of the present invention, the promoter provided above is any promoter in the promoter library.
本發明提供一種表達盒,所述表達盒包括以上所述的啓動子庫中的啓動子。The present invention provides an expression cassette, which comprises the promoter in the promoter library described above.
較佳地,所述表達盒包括以上所述的啓動子庫中的至少一個啓動子。Preferably, the expression cassette comprises at least one promoter in the promoter library described above.
本發明中,表達盒是指將啓動子與目的基因連接後得到的重組核酸分子。In the present invention, the expression cassette refers to a recombinant nucleic acid molecule obtained by connecting a promoter to a target gene.
本發明提供一種載體,所述載體包括以上所述的啓動子庫中的啓動子,或包括以上所述的表達盒。The present invention provides a vector, which comprises the promoter in the promoter library described above, or comprises the expression box described above.
較佳地,所述載體包括以上所述的啓動子庫中的至少一個啓動子。Preferably, the vector comprises at least one promoter from the promoter library described above.
本發明所述的載體可為質粒載體或病毒載體。較佳為表達載體。The vector described in the present invention can be a plasmid vector or a viral vector, preferably an expression vector.
本發明提供一種宿主細胞,所述宿主細胞包括以上所述的啓動子庫中的啓動子,或包括以上所述的表達盒,或包括以上所述的載體。The present invention provides a host cell, wherein the host cell comprises the promoter in the promoter library described above, or comprises the expression box described above, or comprises the vector described above.
較佳地,所述宿主細胞包括以上所述的啓動子庫中的至少一個啓動子。Preferably, the host cell comprises at least one promoter in the promoter library described above.
在所述宿主細胞中,所述啓動子可整合至宿主細胞的染色體上,或者存在於宿主細胞攜帶的質粒載體上。In the host cell, the promoter may be integrated into the chromosome of the host cell, or exist on a plasmid vector carried by the host cell.
以上所述的宿主細胞包括微生物細胞。所述微生物包括但不限於埃希氏菌屬(例如大腸桿菌)、貪銅菌屬(例如羅氏真養菌)、棒桿菌屬(例如谷氨酸棒桿菌)、短桿菌屬、節桿菌屬、微桿菌屬、芽孢桿菌屬、假單胞菌屬、鏈黴菌屬等。The host cells mentioned above include microbial cells. The microorganisms include but are not limited to Escherichia (e.g., Escherichia coli), Coptis (e.g., E. rhodobacterium), Corynebacterium (e.g., Corynebacterium glutamicum), Brevibacterium, Arthrobacterium, Microbacterium, Bacillus, Pseudomonas, Streptomyces, etc.
在本發明的一些實施方式中,所述宿主細胞為大腸桿菌。In some embodiments of the present invention, the host cell is Escherichia coli.
在本發明的一些實施方式中,所述宿主細胞為羅氏真養菌。In some embodiments of the present invention, the host cell is E. rosellae.
本發明提供一種重組工程菌,所述重組工程菌包括以上所述的啓動子庫中的啓動子。The present invention provides a recombinant engineered bacterium, wherein the recombinant engineered bacterium comprises the promoter in the promoter library described above.
較佳地,所述重組工程菌包括以上所述的啓動子庫中的至少一個啓動子。Preferably, the recombinant engineered bacteria comprises at least one promoter in the promoter library described above.
本發明提供以上所述的啓動子庫或所述啓動子或所述表達盒或所述載體或所述宿主細胞的以下任意一種應用: (1)在微生物中調控基因轉錄和/或表達中的應用; (2)在微生物基因編輯中的應用; (3)在微生物基因工程改造中的應用; (4)在用於生產目標產物的工程化微生物構建中的應用; (5)在利用微生物發酵生產目標產物中的應用。 The present invention provides any of the following applications of the promoter library or the promoter or the expression box or the vector or the host cell described above: (1) Application in regulating gene transcription and/or expression in microorganisms; (2) Application in microbial gene editing; (3) Application in microbial genetic engineering; (4) Application in the construction of engineered microorganisms for producing target products; (5) Application in producing target products by microbial fermentation.
上述(1)、(2)中,所述基因包括能夠編碼產生肽或功能RNA的核酸分子。對於基因的種類和序列,本發明沒有特殊限制,可為任意想要轉錄、表達的目的基因。In (1) and (2) above, the gene includes a nucleic acid molecule capable of encoding a peptide or a functional RNA. The type and sequence of the gene are not particularly limited in the present invention, and the gene may be any target gene that is desired to be transcribed and expressed.
上述(4)、(5)中,所述目標產物包括化合物、聚合物或蛋白質,包括但不限於聚酯(例如聚羥基脂肪酸酯)、多酚類化合物、氨基酸或其衍生物、有機酸或其衍生物等。In the above (4) and (5), the target product includes compounds, polymers or proteins, including but not limited to polyesters (such as polyhydroxy fatty acid esters), polyphenol compounds, amino acids or their derivatives, organic acids or their derivatives, etc.
上述(1)-(5)中,所述微生物包括但不限於埃希氏菌屬(例如大腸桿菌)、貪銅菌屬(例如羅氏真養菌)、棒桿菌屬細菌(例如谷氨酸棒桿菌)、短桿菌屬、節桿菌屬、微桿菌屬、芽孢桿菌屬細菌、鏈黴菌、假單胞菌等。In the above (1)-(5), the microorganisms include but are not limited to Escherichia (e.g., Escherichia coli), Cupricinus (e.g., E. rhodobacterium), Corynebacterium (e.g., Corynebacterium glutamicum), Brevibacterium, Arthrobacterium, Microbacterium, Bacillus, Streptomyces, Pseudomonas, etc.
較佳地,所述微生物為大腸桿菌或羅氏真養菌。Preferably, the microorganism is Escherichia coli or E.
本發明提供一種調控基因轉錄和/或表達的方法,所述方法包括將以上所述的啓動子庫中的啓動子與目標基因可操作性地連接的步驟。The present invention provides a method for regulating gene transcription and/or expression, which comprises the step of operably linking the promoter in the promoter library described above to a target gene.
上述調控基因轉錄和/或表達的方法還包括,將以上所述的啓動子庫中的啓動子與目標基因的連接產物導入宿主細胞的步驟。The above method for regulating gene transcription and/or expression further comprises the step of introducing the ligation product of the promoter in the above promoter library and the target gene into a host cell.
本發明提供一種表達系統,其包含以上所述的啓動子庫中的啓動子。The present invention provides an expression system, which comprises the promoter in the promoter library described above.
本發明提供一種在微生物中構建不同表達强度的啓動子庫的方法,所述方法包括將以上所述的包含所述啓動子庫中的啓動子的表達系統轉入不同細菌的步驟。The present invention provides a method for constructing a promoter library with different expression strengths in a microorganism, the method comprising the step of transferring the above-mentioned expression system containing the promoters in the promoter library into different bacteria.
其中,所述微生物包括埃希氏菌屬(例如大腸桿菌)、貪銅菌屬(例如羅氏真養菌)。Wherein, the microorganisms include Escherichia (such as Escherichia coli) and Cupricobacterium (such as E. rhodochii).
在本發明的一些實施方式中,通過DNA組裝技術構建了上述啓動子庫的表達系統,並將所述表達系統轉入不同的細菌中,定量測試啓動子的强度。In some embodiments of the present invention, an expression system of the above promoter library is constructed by DNA assembly technology, and the expression system is transferred into different bacteria to quantitatively test the strength of the promoter.
本發明的有益效果在於:本發明的啓動子庫能夠覆蓋較廣的强度範圍,可以在不同細菌(例如,大腸桿菌和羅氏真養菌)中發揮功能;且相同啓動子在不同細菌中的强度具有較高的一致性,在不同細菌之間具有可移植性,可將其應用於不同的細菌中構建不同表達强度的表達系統,為不同細菌的基因表達調控和工程化細菌的構建提供了重要的生物元件。The beneficial effects of the present invention are as follows: the promoter library of the present invention can cover a wide range of strengths and can function in different bacteria (e.g., Escherichia coli and E. rhodesiae); and the strength of the same promoter in different bacteria is highly consistent and portable between different bacteria, and can be applied to construct expression systems with different expression strengths in different bacteria, providing important biological elements for gene expression regulation of different bacteria and the construction of engineered bacteria.
為使本發明的目的、技術方案和優點更加清楚,下面將結合本發明中的附圖,對本發明中的技術方案進行清楚、完整地描述,顯然,所描述的實施例是本發明一部分實施例,而不是全部的實施例。基於本發明中的實施例,本領域普通技術人員在沒有作出過度實驗前提下所獲得的所有其他實施例,都屬於本發明保護的範圍。In order to make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be described clearly and completely in conjunction with the accompanying drawings. Obviously, the described embodiments are part of the embodiments of the present invention, but not all of the embodiments. Based on the embodiments of the present invention, all other embodiments obtained by ordinary technicians in this field without excessive experiments are within the scope of protection of the present invention.
以下實施例中,所用酶試劑採購自ThermoFisher公司和NewEngland Biolabs(NEB)公司,提取質粒所用的試劑盒購自天根生化科技(北京)有限公司,回收DNA片段的試劑盒購自美國Omega公司,相應的操作步驟嚴格按照產品說明書進行,所有培養基如無特殊說明均用去離子水配製。In the following examples, the enzyme reagents used were purchased from ThermoFisher and New England Biolabs (NEB), the reagent kits used for plasmid extraction were purchased from Tiangen Biochemical Technology (Beijing) Co., Ltd., and the reagent kits for recovering DNA fragments were purchased from Omega Corporation in the United States. The corresponding operating steps were strictly carried out according to the product instructions, and all culture media were prepared with deionized water unless otherwise specified.
以下實施例中使用的培養基配方如下:The culture medium formula used in the following examples is as follows:
1、大腸桿菌培養基1. E. coli culture medium
LB培養基:5g/L 酵母提取物,10g/L 蛋白腖,10g/L 氯化鈉,其餘為水。高溫高壓蒸汽(121℃,20min)滅菌。LB medium: 5g/L yeast extract, 10g/L peptone, 10g/L sodium chloride, the rest is water. Sterilize with high temperature and high pressure steam (121℃, 20min).
2、羅氏真養菌培養基2. Eubacterium rosea culture medium
TYGA培養基:5g/L 酵母提取物,10g/L 蛋白腖,3g/L 葡萄糖,3g/L 硫酸銨,其餘為水。高溫高壓蒸汽(121℃,20min)滅菌。TYGA medium: 5g/L yeast extract, 10g/L peptone, 3g/L glucose, 3g/L ammonium sulfate, and the rest is water. Sterilize with high temperature and high pressure steam (121℃, 20min).
在實際培養過程中,可向上述培養基中加入一定濃度的抗生素以維持質粒的穩定性,如100μg/mL氨苄青黴素或20μg/mL的四環素。In the actual culture process, a certain concentration of antibiotics can be added to the above culture medium to maintain the stability of the plasmid, such as 100 μg/mL ampicillin or 20 μg/mL tetracycline.
以下實施例中,含有啓動子庫的表達系統的原理示意圖見圖1。啓動子調控綠色螢光蛋白的表達,通過流式細胞儀檢測螢光强度,進而以螢光强度值來定量表徵啓動子的强度。In the following examples, the principle schematic diagram of the expression system containing the promoter library is shown in Figure 1. The promoter regulates the expression of green fluorescent protein, and the fluorescence intensity is detected by flow cytometry, and the fluorescence intensity value is used to quantitatively characterize the strength of the promoter.
實施例1 大腸桿菌中含啓動子庫的表達系統的構建和測試Example 1 Construction and testing of an expression system containing a promoter library in Escherichia coli
通過藥明康德公司合成包含啓動子原始序列(編號為0),sfGFP基因等測試序列的pBBR1質粒(質粒結構見圖2),以此質粒作為模板,通過PCR擴增獲得兩個片段,引子和擴增產物訊息如表1所示。The pBBR1 plasmid containing the original sequence of the promoter (numbered 0), the sfGFP gene and other test sequences was synthesized by WuXi AppTec (see Figure 2 for the plasmid structure). This plasmid was used as a template to obtain two fragments through PCR amplification. The primers and amplification product information are shown in Table 1.
表1
其中,lib-P1-F為簡並引子(n代表a、t、c、g中任意一種),通過該設計在啓動子-10區引入3個鹼基的飽和突變以構建啓動子庫。將PCR得到兩個片段經過純化後,以Gibson Assembly的連接方式得到pBBR1-promoter_lib1,質粒轉入大腸桿菌中得到啓動子庫。啓動子庫中的啓動子序列如下(SEQ ID NO.1): ttcgtcaggccacatagctttcttgttctgatcggaacgatcgttggctgtg aaaaaatttat ttgcttagcccgacgcccgcggg nnnaata gaattcactagtttaactttaagaa(其中,n代表a、t、c、g中任意一種)。 Among them, lib-P1-F is a degenerate primer (n represents any one of a, t, c, and g). Through this design, a saturated mutation of three bases is introduced in the promoter-10 region to construct a promoter library. After the two fragments obtained by PCR are purified, pBBR1-promoter_lib1 is obtained by connecting by Gibson Assembly, and the plasmid is transformed into Escherichia coli to obtain a promoter library. The promoter sequence in the promoter library is as follows (SEQ ID NO.1): ttcgtcaggccacatagctttcttgttctgatcggaacgatcgttggctgtg aaaaaatttat ttgctt agcccgacgcccgcggg nnnaat a gaattcactagtttaactttaagaa (where n represents any one of a, t, c, and g).
轉化後得到的大腸桿菌中,每個陽性單克隆中包含一個啓動子,其序列對應於SEQ ID NO.1,隨機選取啓動子庫中的陽性克隆,測序後確定序列。共得到40個不同的啓動子序列(表2)。Each positive single clone of E. coli obtained after transformation contained a promoter, and its sequence corresponded to SEQ ID NO.1. The positive clones in the promoter library were randomly selected and sequenced to determine the sequence. A total of 40 different promoter sequences were obtained (Table 2).
表2
將上述含有不同啓動子的大腸桿菌陽性克隆在LB培養基中活化培養後,採用流式細胞儀檢測螢光强度,螢光强度動態範圍達10 3,結果如圖3所示。含有上述啓動子序列的大腸桿菌的螢光强度值如表3所示。 After activating and culturing the above-mentioned E. coli positive clones containing different promoters in LB medium, the fluorescence intensity was detected by flow cytometry, and the dynamic range of the fluorescence intensity reached 10 3 , as shown in Figure 3. The fluorescence intensity values of E. coli containing the above-mentioned promoter sequences are shown in Table 3.
表3
實施例2 羅氏真養菌中含啓動子庫的表達系統的構建和測試Example 2 Construction and testing of an expression system containing a promoter library in E.
將實施例1中構建的上述啓動子庫的質粒通過接合轉化轉入羅氏真養菌,得到含啓動子庫的表達系統。將含有不同啓動子的羅氏真養菌在TYGA培養基中活化培養後用流式細胞儀檢測螢光强度,螢光强度動態範圍達10 3倍,結果如圖4所示。含有上述啓動子序列的羅氏真養菌的螢光强度值如表4所示。 The plasmid of the promoter library constructed in Example 1 was transferred into E. rhodesi by conjugation transformation to obtain an expression system containing the promoter library. E. rhodesi containing different promoters were activated and cultured in TYGA medium, and the fluorescence intensity was detected by flow cytometry. The dynamic range of the fluorescence intensity reached 10 3 times, as shown in Figure 4. The fluorescence intensity values of E. rhodesi containing the promoter sequence are shown in Table 4.
表4
以啓動子庫中同一個啓動子在大腸桿菌中的表達强度為橫軸,在羅氏真養菌中表達强度為縱軸,製作散點圖,並對所有的點作擬合曲線,確定係數R 2達到0.9183,結果如圖5所示。結果表明,本發明的啓動子庫在大腸桿菌和羅氏真養菌之間具有很好的表達强度一致性。 A scatter plot was made with the expression intensity of the same promoter in the promoter library in Escherichia coli as the horizontal axis and the expression intensity in E. rhodesiae as the vertical axis, and a fitting curve was made for all the points. The coefficient of determination R2 reached 0.9183, as shown in Figure 5. The results show that the promoter library of the present invention has good consistency in expression intensity between E. coli and E. rhodesiae.
最後應說明的是:以上實施例僅用以說明本發明的技術方案,而非對其限制;儘管參照前述實施例對本發明進行了詳細的說明,本領域的普通技術人員應當理解:其依然可以對前述各實施例所記載的技術方案進行修改,或者對其中部分技術特徵進行等同替換;而這些修改或者替換,並不使相應技術方案的本質脫離本發明各實施例技術方案的精神和範圍。Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention, rather than to limit it. Although the present invention has been described in detail with reference to the above embodiments, ordinary technical personnel in this field should understand that they can still modify the technical solutions described in the above embodiments, or replace some of the technical features therein with equivalents. However, these modifications or replacements do not deviate the essence of the corresponding technical solutions from the spirit and scope of the technical solutions of the embodiments of the present invention.
無without
為了更清楚地說明本發明或習知技術中的技術方案,下面將對實施例或習知技術描述中所需要使用的附圖作一簡單地介紹,顯而易見地,下面描述中的附圖是本發明的一些實施例,對於本領域普通技術人員來講,在不付出過度實驗的前提下,還可以根據這些附圖獲得其他的附圖。In order to more clearly illustrate the technical solutions in the present invention or the prior art, the drawings required for use in the embodiments or the description of the prior art will be briefly introduced below. Obviously, the drawings described below are some embodiments of the present invention. For ordinary technical personnel in this field, other drawings can be obtained based on these drawings without excessive experiments.
圖1為本發明的含有啓動子庫的表達系統的構建和測試的原理示意圖。 圖2為本發明實施例1中的質粒圖譜。 圖3為本發明實施例1中啓動子庫在大腸桿菌中的表達强度。 圖4為本發明實施例2中啓動子庫在羅氏真養菌中的表達强度。 圖5為本發明實施例2中啓動子庫在大腸桿菌和羅氏真養菌中的表達强度相關性。 Figure 1 is a schematic diagram of the principle of construction and testing of the expression system containing the promoter library of the present invention. Figure 2 is a plasmid map in Example 1 of the present invention. Figure 3 is the expression intensity of the promoter library in Escherichia coli in Example 1 of the present invention. Figure 4 is the expression intensity of the promoter library in E. coli in Example 2 of the present invention. Figure 5 is the correlation of the expression intensity of the promoter library in E. coli and E. coli in Example 2 of the present invention.
TW202411429A_112144768_SEQL.xmlTW202411429A_112144768_SEQL.xml
Claims (10)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202310525523.7A CN116254268B (en) | 2023-05-11 | 2023-05-11 | Promoter library and application thereof in different bacteria |
CN2023105255237 | 2023-05-11 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW202411429A true TW202411429A (en) | 2024-03-16 |
Family
ID=86688323
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW112144768A TW202411429A (en) | 2023-05-11 | 2023-11-20 | Promoter library and application thereof in different bacteria |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN116254268B (en) |
TW (1) | TW202411429A (en) |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105779488B (en) * | 2016-03-23 | 2018-06-22 | 清华大学 | The system and its application that a kind of induction exogenous gene is expressed in Gram-negative bacteria |
CN108977890B (en) * | 2017-06-05 | 2022-02-15 | 北京蓝晶微生物科技有限公司 | Promoter library and method for constructing expression systems with different intensities in bacteria by using same |
JP2020524494A (en) * | 2017-06-06 | 2020-08-20 | ザイマージェン インコーポレイテッド | High throughput transposon mutagenesis |
CN107312790A (en) * | 2017-06-26 | 2017-11-03 | 中国科学技术大学 | A kind of programmable many specific Transcription inhibition systems in site and its application |
FI3655422T3 (en) * | 2017-07-21 | 2023-06-13 | Basf Se | Promoter for heterologous expression |
CN111979163B (en) * | 2019-05-24 | 2022-05-06 | 深圳蓝晶生物科技有限公司 | Recombinant Roche bacterium, preparation method and application thereof |
CN114381415B (en) * | 2022-03-22 | 2022-11-15 | 深圳蓝晶生物科技有限公司 | Gene recombination strain for high-yield PHA and construction method thereof |
-
2023
- 2023-05-11 CN CN202310525523.7A patent/CN116254268B/en active Active
- 2023-11-20 TW TW112144768A patent/TW202411429A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN116254268A (en) | 2023-06-13 |
CN116254268B (en) | 2023-08-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20090246838A1 (en) | Process For The Production Of Cadaverine | |
BR112015020274B1 (en) | STRAIN PRODUCING L-VALINE TRANSFORMED TO IMPROVE THE EXPRESSION OF THE LVALINE OPERON, METHOD FOR THE PRODUCTION OF L-VALINE AND VARIANT OF THE REGULATORY REGION OF THE L-VALINE OPERON | |
CN106029879B (en) | Microorganism having improved L-threonine-producing ability and method for producing L-threonine using the same | |
CN108977890B (en) | Promoter library and method for constructing expression systems with different intensities in bacteria by using same | |
CN104651287A (en) | Engineering bacterium for synthesizing glycosylglycerol and application thereof | |
EP3978603A1 (en) | A butyric acid-producing bacillus subtilis strain, method of construction and application thereof | |
CN111926002B (en) | TrpE mutant and application thereof in gene engineering bacteria for producing L-tryptophan | |
TW202411429A (en) | Promoter library and application thereof in different bacteria | |
TW201538724A (en) | Microorganisms producing L-amino acids and process for producing L-amino acids using the same | |
CN111004761A (en) | L-tyrosine gene engineering bacterium, method for producing L-tyrosine by using same and application thereof | |
CN1908159B (en) | D-amino acid preparation strain and construction method thereof | |
TW202411428A (en) | Microbial promoter library and application thereof | |
JP6991897B2 (en) | Nucleic acids and vectors for controlling gene expression in non-phototrophic C1 metabolizing microorganisms, and transformants thereof | |
JP2019518453A (en) | Method for producing D-xylonate and coryneform bacterium | |
CN108611357B (en) | Recombinant expression plasmid, transformant and application thereof | |
CN116769808A (en) | Strain for specifically producing 2' -fucosyllactose and application thereof | |
EP4341407A1 (en) | Microorganism strain and method for antibiotic-free plasmid-based fermentation | |
CN114854659A (en) | Ergothioneine production process and application thereof | |
KR102546140B1 (en) | Kit for Selecting Host Cells Transformed with Target Gene using Clustered Regularly Interspaced Short Palindromic Repeats Interference System and Uses Thereof | |
CN118086167B (en) | Genetically engineered bacterium for producing L-tryptophan and construction method and application thereof | |
CN110872595A (en) | Acid-resistant expression cassette and application thereof in organic acid production by fermentation | |
KR102590534B1 (en) | Method for the production of cadaverine with Hafnia Alvei as biocatalizer | |
Sánchez et al. | Microbial Synthesis of Secondary Metabolites and Strain Improvement: Current Trends and Future Prospects | |
KR102166288B1 (en) | D-glutamate auxotrophic Escherichia coli and method of producing target product | |
Zhang et al. | Simultaneous multiplex genome loci editing of Halomonas bluephagenesis using an engineered CRISPR-guided base editor |